Sirona Biochem Corp. (SRBCF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.75 Million | -2.17 Million | -2.15 Million | -2.11 Million | -3.55 Million | -653.8 Thousand |
| Net Income | -2.54 Million | -3.55 Million | -2.3 Million | -4.13 Million | -4.54 Million | -1.27 Million |
| Depreciation & Amortization | 9709.00 | 9091.00 | 9459.00 | 9695.00 | -86.21 Thousand | -114.44 Thousand |
| Deferred income taxes | -954.00 | 5954.00 | 5681.00 | -7076.00 | -6208.00 | 3733.00 |
| Stock-based compensation | 30.5 Thousand | 1.46 Million | 331.4 Thousand | 1.62 Million | 1.05 Million | 98.31 Thousand |
| Change in working capital | 553.06 Thousand | -295.47 Thousand | -198.44 Thousand | 393.39 Thousand | 455.00 | 363.92 Thousand |
| Other non-cash items | 193.35 Thousand | 195.75 Thousand | 597.22 Thousand | 2456.00 | 25.09 Thousand | 243.43 Thousand |
| Investing Cash Flow | - | - | - | -46.97 Thousand | - | - |
| Investments in PPE | - | - | - | -46.97 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.74 Million | 2.03 Million | 1.45 Million | -45.95 Thousand | 6.96 Million | 722.03 Thousand |
| Debt repayment | -1.73 Million | -338.37 Thousand | -308.26 Thousand | -133.38 Thousand | -240.6 Thousand | -119.73 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 52.5 Thousand | 2.37 Million | 1.75 Million | 87.42 Thousand | 3.13 Million | 597.3 Thousand |
| Other Financing Activities | 3.42 Million | 2.37 Million | 1.75 Million | 87.42 Thousand | 4.06 Million | 124.73 Thousand |
| Accounts receivables | 199.57 Thousand | -360.42 Thousand | 47.78 Thousand | -34.49 Thousand | -145.37 Thousand | 408.29 Thousand |
| Accounts payables | 287.38 Thousand | 87.57 Thousand | -294.68 Thousand | 411.88 Thousand | 59.3 Thousand | -4515.00 |
| Inventory | - | 272.85 Thousand | 246.89 Thousand | -377.38 Thousand | 145.37 Thousand | - |
| Other working capital | 66.1 Thousand | -295.47 Thousand | -198.44 Thousand | 393.39 Thousand | -58.85 Thousand | 368.43 Thousand |
| Cash at beginning of period | 421.51 Thousand | 778 Thousand | 1.53 Million | 3.73 Million | 339.07 Thousand | 272.27 Thousand |
| Cash at end of period | 571.49 Thousand | 421.51 Thousand | 778 Thousand | 1.53 Million | 3.73 Million | 339.07 Thousand |
| Capital Expenditure | - | - | - | -46.97 Thousand | - | - |
| Effect of forex changes on cash | 157.96 Thousand | -215.63 Thousand | -49.68 Thousand | 6256.00 | -8927.00 | -1436.00 |
| Net cash flow / Change in cash | 149.97 Thousand | -356.48 Thousand | -757.86 Thousand | -2.19 Million | 3.39 Million | 66.8 Thousand |
| Free Cash Flow | -1.75 Million | -2.17 Million | -2.15 Million | -2.15 Million | -3.55 Million | -653.8 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -885.18 Thousand | -417.95 Thousand | -731.91 Thousand | -631.28 Thousand | -2.54 Million | -525.67 Thousand |
| Depreciation & Amortization | 2564.00 | 2454.00 | 2401.00 | 2543.00 | 9709.00 | 2376.00 |
| Deferred income taxes | 1858.00 | -621.00 | 543.00 | 1053.00 | -954.00 | -637.00 |
| Stock-based compensation | 1.00 | - | 188.39 Thousand | -1.00 | 30.5 Thousand | - |
| Change in working capital | 123.22 Thousand | -268.88 Thousand | -83.89 Thousand | 264.38 Thousand | 553.06 Thousand | -80.23 Thousand |
| Other non-cash items | 68.18 Thousand | -25.04 Thousand | 81.33 Thousand | 121.34 Thousand | 193.35 Thousand | 64.75 Thousand |
| Investing Cash Flow | - | - | -1.00 | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 556.13 Thousand | 602.28 Thousand | 84.48 Thousand | 355.49 Thousand | 1.74 Million | -59.03 Thousand |
| Debt repayment | -483.63 Thousand | -385.23 Thousand | -84.48 Thousand | -391.03 Thousand | -1.73 Million | -59.03 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10 Thousand | 217.05 Thousand | - | - | 52.5 Thousand | - |
| Other Financing Activities | 72.5 Thousand | - | - | 746.52 Thousand | 3.42 Million | -59.03 Thousand |
| Accounts receivables | -327.47 Thousand | -257.3 Thousand | 289.99 Thousand | 173.37 Thousand | 199.57 Thousand | -404.76 Thousand |
| Accounts payables | - | 284.31 Thousand | -482.76 Thousand | 164.65 Thousand | 287.38 Thousand | 53.03 Thousand |
| Inventory | - | - | - | - | - | 351.73 Thousand |
| Other working capital | 120.19 Thousand | -295.89 Thousand | 108.88 Thousand | -73.63 Thousand | 66.1 Thousand | -80.23 Thousand |
| Cash at beginning of period | 27.29 Thousand | 112.25 Thousand | 571.49 Thousand | 308.84 Thousand | 421.51 Thousand | 907.85 Thousand |
| Cash at end of period | 32.87 Thousand | 27.29 Thousand | 112.25 Thousand | 571.49 Thousand | 571.49 Thousand | 308.84 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 2041.00 | 71.00 | -586.00 | 149.11 Thousand | 157.96 Thousand | -562.00 |
| Net cash flow / Change in cash | 5583.00 | -84.96 Thousand | -459.23 Thousand | 262.64 Thousand | 149.97 Thousand | -599.01 Thousand |
| Free Cash Flow | -552.59 Thousand | -687.32 Thousand | -543.13 Thousand | -241.95 Thousand | -1.75 Million | -539.41 Thousand |
000096
HPYCF
2344
600269
QNI
INGR